Chief Scientific OfficeMarea TherapeuticsSouth San Francisco, California, United States
Disclosure information not submitted.
ORF28-08 - A First-in-Human Study of A Novel Growth Hormone Receptor Antagonist Antibody in Healthy Men Demonstrates Translational Potential for Acromegaly
Sunday, June 14, 20263:00 PM - 3:15 PM CT